From Research Lab to CEO: Michael Torres on Innovation in Cancer Care_e.058

Join us on Lab Rats to Unicorns as we dive into the career of Michael Torres, CEO of Crossbridge Bio. With a Ph.D. in cancer biology and a background in equity research, Michael has been at the forefront of developing cutting-edge oncology treatments. In this episode, he discusses the evolution of antibody-drug conjugates (ADCs) and the process of building biotech companies in the Texas innovation ecosystem, as well as his personal journey from researcher to CEO. 

Episode metadata supplied by the publisher feed · Published Sep 26, 2024

Embed this episode

Attribution link and audio player

Ready to play

From Research Lab to CEO: Michael Torres on Innovation in Cancer Care_e.058

0:00 56:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lab Rats to Unicorns?

This episode is 56 minutes long.

When was this Lab Rats to Unicorns episode published?

This episode was published on September 26, 2024.

Can I download this Lab Rats to Unicorns episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!